Rapt Therapeutics Inc (RAPT)

Jul 03, 2026

RAPT Therapeutics outlines its immunology pipeline as investors weigh long-term prospects - Ad Hoc News

Jul 03, 2026

Jun 23, 2026

RAPT Therapeutics Inc (RAPT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026

Jun 17, 2026

RAPT Therapeutics Inc (RAPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

RAPT Therapeutics Inc (RAPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

RAPT Therapeutics Inc (RAPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

RAPT Therapeutics Inc (RAPT) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 17, 2026

RAPT Therapeutics Inc (RAPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

RAPT Therapeutics Inc (RAPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

RAPT Therapeutics Inc (RAPT) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

RAPT Therapeutics Inc (RAPT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 11, 2026

TD Cowen initiates coverage of RAPT Therapeutics (RAPT) with buy recommendation - MSN

Jun 11, 2026

May 29, 2026

RAPT Therapeutics prices equity offering at $30 per share - MSN

May 29, 2026

May 18, 2026

Analyst Lifts RAPT Therapeutics Price Target to $56 and Reiterates Buy on RAP-219 Seizure Data Upside - TipRanks

May 18, 2026

May 15, 2026

OrbiMed files Amendment to 13G, reports 0 RAPT shares (NASDAQ: RAPT) - Stock Titan

May 15, 2026

May 15, 2026

RTW Investments amends Schedule 13G/A for RAPT (NASDAQ: RAPT) - Stock Titan

May 15, 2026

May 12, 2026

RAPT Therapeutics stock (US74933X1090): Biotech innovator in immunology - AD HOC NEWS

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 07, 2026

Piper Sandler initiated coverage on RAPT Therapeutics with a new price target - Quantisnow

May 07, 2026

Apr 26, 2026

RAPT Therapeutics (RAPT) Investor Update Summary - Quartr

Apr 26, 2026

Apr 25, 2026

RAPT Price Today: RAPT Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 25, 2026

Apr 25, 2026

RAPT Therapeutics (RAPT) Wells Fargo 20th Annual Healthcare Conference 2025 summary - Quartr

Apr 25, 2026

Apr 25, 2026

RAPT Therapeutics (RAPT) 44th Annual J.P. Morgan Healthcare Conference Summary - Quartr

Apr 25, 2026

Apr 25, 2026

RAPT Therapeutics (RAPT) Study Result Summary - Quartr

Apr 25, 2026

Apr 25, 2026

RAPT Therapeutics (RAPT) Stifel Virtual Immunology and Inflammation Forum Summary - Quartr

Apr 25, 2026

Apr 25, 2026

RAPT Therapeutics (RAPT) Leerink’s Global Healthcare Conference 2025 Summary - Quartr

Apr 25, 2026

Apr 25, 2026

RAPT Therapeutics (RAPT) Proxy Filing Summary - Quartr

Apr 25, 2026

Apr 25, 2026

RAPT Therapeutics (RAPT) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary - Quartr

Apr 25, 2026

Apr 13, 2026

RAPT Therapeutics (RAPT) price target decreased by 12.94% to 54.97 - MSN

Apr 13, 2026

Apr 12, 2026

Targets Report: Is RAPT Therapeutics Inc stock influenced by commodity prices2026 Highlights & Weekly High Return Opportunities - baoquankhu1.vn

Apr 12, 2026

Apr 11, 2026

Rate Cut: Can RAPT Therapeutics Inc deliver alphaQuarterly Investment Review & Verified Swing Trading Watchlist - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

Rapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why - MSN

Apr 10, 2026

Apr 10, 2026

Trade Recap: Can RAPT Therapeutics Inc deliver alpha2026 News Drivers & AI Forecasted Stock Moves - baoquankhu1.vn

Apr 10, 2026

Apr 07, 2026

Smart Money: Is RAPT Therapeutics Inc a speculative investment2026 Biggest Moves & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 07, 2026

Mar 30, 2026

RAPT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 30, 2026

Mar 30, 2026

Aug Fed Impact: Can RAPT Therapeutics Inc deliver alpha2026 Market Outlook & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Rapt Therapeutics synthesizes new TNF-α modulators - BioWorld News

Mar 30, 2026

Mar 25, 2026

Performance Recap: Can RAPT Therapeutics Inc benefit from deglobalization2026 Key Highlights & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Mar 25, 2026

Mar 23, 2026

Barclays Maintains RAPT Therapeutics (RAPT) Overweight Recommendation - msn.com

Mar 23, 2026

Mar 22, 2026

Aug Weekly: Is RAPT Therapeutics Inc a speculative investment2026 Price Action Summary & Short-Term High Return Strategies - baoquankhu1.vn

Mar 22, 2026

Mar 22, 2026

If You Invested $1,000 in Rapt Therapeutics, Inc. (RAPT) - Stock Titan

Mar 22, 2026

Mar 21, 2026

This Biotech Was Quietly Bought Before a $58 Per Share Takeout - AOL.com

Mar 21, 2026

Mar 18, 2026

[15-12G] RAPT Therapeutics, In... - Stock Titan

Mar 18, 2026

Mar 16, 2026

This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share - AOL.com

Mar 16, 2026

Mar 15, 2026

This investor accumulated a $56 million stake in RAPT during the previous quarter. The company has now been bought out at $58 per share. - Bitget

Mar 15, 2026

Mar 10, 2026

Rapt Therapeutics Receives $48.44 Average Target Price from Analysts - National Today

Mar 10, 2026

Mar 07, 2026

Insider Sell: What analysts say about RAPT Therapeutics Inc. stockRate Cut & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

GSK to buy Rapt Therapeutics in deal valued at $2.2B - MSN

Mar 07, 2026

Mar 07, 2026

RAPT SEC FilingsRapt Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 07, 2026

Mar 07, 2026

Rapt Therapeutics (NASDAQ:RAPT) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Mar 07, 2026

Mar 05, 2026

GSK reached out to buyout target's big shareholder before talking to senior leadersSan Francisco Business Times - The Business Journals

Mar 05, 2026

Mar 05, 2026

RAPT (RAPT) director equity awards cashed out in $58-per-share GSK deal - Stock Titan

Mar 05, 2026

Mar 05, 2026

RAPT Therapeutics (RAPT) director equity cashed out in $58-per-share GSK buyout - Stock Titan

Mar 05, 2026

Mar 05, 2026

RAPT Therapeutics (RAPT) director equity cashed out in $58 GSK deal - Stock Titan

Mar 05, 2026

Mar 05, 2026

RAPT (RAPT) director disposes equity as $58-per-share GSK merger closes - Stock Titan

Mar 05, 2026

Mar 05, 2026

GSK acquisition cashes out RAPT (RAPT) CFO shares and options - Stock Titan

Mar 05, 2026

Mar 05, 2026

RAPT Therapeutics (RAPT) director exits options and shares in GSK deal - Stock Titan

Mar 05, 2026

Mar 05, 2026

GSK deal: RAPT (RAPT) director disposes options and shares - Stock Titan

Mar 05, 2026